AATec Medical GmbH | WebDisclosure

BRIEF

published on 04/15/2025 at 11:09, 1 month 15 days ago

AATec Medical Secures EUR 4 Million for Respiratory Drug Development

Biotechnology Funding Clinical Trials Drug Development Respiratory Diseases
BRIEF

published on 04/15/2025 at 11:09, 1 month 15 days ago

AATec Medical obtient 4 millions d'euros pour le développement de médicaments respiratoires

Biotechnologie Financement Essais Cliniques Développement De Médicaments Maladies Respiratoires
PRESS RELEASE

published on 04/15/2025 at 11:04, 1 month 15 days ago

AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development
AATec Medical secures EUR 4 million funding to advance lead respiratory drug candidate, ATL-105, for clinical development to treat non-CF bronchiectasis by 2026

Clinical Development AATec Medical Non-CF Bronchiectasis EUR 4 Million Respiratory Drug Candidate
BRIEF

published on 09/18/2024 at 10:05, 8 months 12 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board

Scientific Advisory Board AATec Medical James Chalmers Bronchiectasis Recombinant AAT
BRIEF

published on 09/18/2024 at 10:05, 8 months 12 days ago

AATec Medical accueille le professeur James Chalmers au sein de son conseil consultatif scientifique

AATec Medical Conseil Consultatif Scientifique James Chalmers Bronchectasie AAT Recombinante
PRESS RELEASE

published on 09/18/2024 at 10:00, 8 months 12 days ago

AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board
AATec Medical welcomes Professor James Chalmers, a renowned expert in respiratory medicine, to its Scientific Advisory Board to advance product development in non-CF bronchiectasis

Scientific Advisory Board AATec Medical Professor James Chalmers Respiratory Medicine Non-CF Bronchiectasis
BRIEF

published on 07/24/2024 at 10:05, 10 months 7 days ago

AATec Medical Makes Significant Strides in First Year of Operations

Biotechnology Clinical Trials AATec Medical ATL-105 Inflammatory Lung Diseases
BRIEF

published on 07/24/2024 at 10:05, 10 months 7 days ago

AATec Medical réalise des progrès significatifs au cours de sa première année d'exploitation

Biotechnologie AATec Medical ATL-105 Essais Cliniques Maladies Pulmonaires Inflammatoires
PRESS RELEASE

published on 07/24/2024 at 10:00, 10 months 7 days ago

AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT
AATec Medical reports significant progress in unlocking therapeutic potential of AAT for treating inflammatory lung diseases in its first year. Company advances lead candidate ATL-105 for NCFB

AATec Medical ATL-105 Inflammatory Lung Diseases Therapeutic Potential NCFB
BRIEF

published on 02/29/2024 at 09:30, 1 year 3 months ago

AATec Medical enrichit son Conseil Scientifique avec l'arrivée du Professeur Claus Franz Vogelmeier

AATec Medical Professeur Claus Franz Vogelmeier Maladies Inflammatoires Pulmonaires Conseil Scientifique Alpha-1 Antitrypsine

Published on 05/31/2025 at 06:16, 1 day 3 hours ago

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Published on 05/31/2025 at 03:30, 1 day 6 hours ago

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders
Published on 05/31/2025 at 01:45, 1 day 7 hours ago

GLG Life Tech Corporation Reports 2025 First Quarter Financial Results
Published on 05/30/2025 at 23:10, 1 day 10 hours ago

CORRECTION: Nextech3D.ai Migrates MAP Dynamics to AWS, Enabling Scalable AI Architecture and Accelerated Deployment
Published on 05/30/2025 at 23:00, 1 day 10 hours ago

Battery X Metals Achieves Full Capacity Recovery on a Real-World Imbalanced Battery from the #2 Out-of-Warranty Electric Vehicle Model in the United States in Preliminary Trial

View all ACCESSWIRE

Published on 05/31/2025 at 21:00, 12 hours 44 minutes ago

Leclanché annonce le dépôt d'une demande de prolongation du délai de publication du rapport annuel 2024 et la suspension temporaire de la cotation de ses actions nominatives à la SIX Swiss Exchange
Published on 05/31/2025 at 21:00, 12 hours 44 minutes ago

Leclanché SA: Leclanché announces filing of request to extend the publication deadline for the 2024 Annual Report and the temporary suspension of trading of its registered shares on SIX Swiss Exchange
Published on 05/31/2025 at 18:37, 15 hours 7 minutes ago

Meyer Burger files for insolvency for German subsidiaries
Published on 05/31/2025 at 14:50, 18 hours 53 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/31/2025 at 14:46, 18 hours 58 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

View all EQS

Published on 05/30/2025 at 22:00, 1 day 11 hours ago

Information sur les comptes annuels
Published on 05/30/2025 at 22:00, 1 day 11 hours ago

Information on the Annual Financial Statements
Published on 05/30/2025 at 18:14, 1 day 15 hours ago

Emova Group - Rapport annuel de Durabilité 23/24
Published on 05/28/2025 at 23:00, 3 days 10 hours ago

Standstill Commitments to hold shares of the company
Published on 05/28/2025 at 23:00, 3 days 10 hours ago

Engagements collectifs de conservation de titres de la société

View all LES ECHOS COMFI WIRE

News